HCC Clinical Trials
3 recruiting trials for HCC. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2 / Phase 3NCT06844357
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver...
This phase I/II clinical trial aims to determine the efficacy and safety of TATE compared to TACE in patients with intermediate-stage HCC. The results will provide valuable...
Sponsor: Zhejiang Raygene Pharmaceuticals Co., LtdEnrolling: 3002 locations
RECRUITINGPhase 1 / Phase 2NCT06527495
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
The current study will aim to maximize the therapeutic effect and to minimize the adverse effects of sorafenib in HCC through pharmacogenomic analysis of VEGFA and KDR genetic...
Sponsor: Assiut UniversityEnrolling: 1501 location
RECRUITINGPhase 1NCT06617000
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
This is a Phase I clinical study aimed to assess the safety, tolerability, and efficacy of SCG101 monotherapy for patients with HBV-HCC.
Sponsor: SCG Cell Therapy Pte. Ltd.Enrolling: 387 locations